PRGO

PRGO

USD

Perrigo Company plc Ordinary Shares

$20.190-0.300 (-1.464%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Iirimaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$20.490

Kõrge

$20.620

Madal

$20.180

Maht

12.00M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

2.8B

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

Ireland

Kauplemisstatistika

Keskmine maht

1.94M

Börs

NYQ

Valuuta

USD

52 nädala vahemik

Madal $20.18Praegune $20.190Kõrge $30.93

Seotud uudised

PR Newswire

Perrigo to Attend Jefferies Consumer Conference

Perrigo Company plc (NYSE: PRGO), a leading provider of consumer health products, today announced that President and CEO Patrick Lockwood-Taylor and...

Vaata rohkem
Reuters

Drugmakers must face skincare drug price-fixing lawsuit, US judge rules

A federal judge on Friday said 36 drugmakers and executives must face nearly all claims in an antitrust lawsuit brought by most U.S. states, accusing them of conspiring to fix prices of 80 generic drugs.

Vaata rohkem
Drugmakers must face skincare drug price-fixing lawsuit, US judge rules
PR Newswire

Perrigo Announces Quarterly Dividend

Perrigo Company plc (NYSE: PRGO), a leading global provider of consumer health products, today announced that its Board of Directors declared a...

Vaata rohkem
Perrigo Announces Quarterly Dividend
Analyst Upgrades

Jefferies Maintains Hold on Perrigo, Lowers Price Target to $23

Jefferies analyst Keith Devas maintains Perrigo with a Hold and lowers the price target from $27 to $23.

Vaata rohkem
Jefferies Maintains Hold on Perrigo, Lowers Price Target to $23
PR Newswire

Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025

Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that it plans to issue its third quarter 2025...

Vaata rohkem
Perrigo to Release Third Quarter 2025 Financial Results on November 5, 2025

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.